Z-1493-2021 Class II Ongoing

Recalled by Cytocell Ltd. — Cambridge, N/A

FDA device recall Z-1493-2021 was initiated by Cytocell Ltd. on Mar 19, 2021 and is designated Class II. Reason for recall: Users may observe additional locus specific signals at 9q34. The device pack insert indicates the probe has no known cross-reactivity to 9q34. The recall status is ongoing. Affected quantity: 89 probes.

Recall details

Product Type
Devices
Report Date
May 5, 2021
Initiation Date
Mar 19, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
89 probes

Product description

Chromosome X Alpha-Satellite in FITC Spectrum - Product Usage: Analyte Specific Reagents. Model: MPA3481

Reason for recall

Users may observe additional locus specific signals at 9q34. The device pack insert indicates the probe has no known cross-reactivity to 9q34.

Distribution pattern

US Nationwide distribution in the states of TX, OH, NY, IL, CT, AL, IA, MO.

Code information

Lot: RD20/253/16, RD21/043/01, RD21/043/02

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1493-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1493-2021. Report a data issue: hello@regdatalab.com.